Cartina health's $1.115 billion acquisition of Harvard Pharmaceutical Group
-
Last Update: 2015-06-08
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Source: Sina Finance / Yujian 2015-06-08 evening news on June 5, Beijing time, US health care product and service provider Cardinal Health Inc announced on Friday that it had agreed to acquire the privately held generic drug distributor Harvard drug group with a transaction price of about 11.15 Billion dollars Cartina said the deal is expected to increase its 2016 earnings per share by more than 15 cents to $4.75-5.05 Harvard Pharmaceutical Group has 450 employees and two distribution centers, with revenues of about $450 million in 2014 (original title: cartina health's US $1.12 billion acquisition of Harvard Pharmaceutical Group)
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
